Terminalcare Support Institute, Inc. (7362) AI Stock Analysis

• Market Cap: ¥1.20B
• Dividend Yield: N/A
• Average Volume (3M): 2.46K
• Price to Earnings (P/E): 13.1
• Beta (1Y): 0.38
• Revenue Growth: 7.06%
• EPS Growth: -27.80%
• Country: JP
• Employees: 451
• Sector: Healthcare
• Sector Strength: 44
• Industry: Medical - Care Facilities
• EPS (TTM): -19.05
• Shares Outstanding: 1,533,100
• 10 Day Avg. Volume: 1,250
• 30 Day Avg. Volume: 2,463
• PEG Ratio: 2.17
• Price to Book (P/B): 2.99
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 10.69
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 66 Neutral
• Price Target: ¥842.00 ▲(7.81%Upside)

The overall stock score is primarily influenced by solid financial performance, despite challenges in cash flow management. Technical analysis indicates neutral momentum, and the reasonable valuation adds moderate support to the score. The exclusion of earnings call and corporate events data limits further insights.

Terminalcare Support Institute, Inc. Business Overview & Revenue Model

Company Description

Terminalcare Support Institute, Inc. (7362) is a healthcare organization that specializes in providing comprehensive support services for terminally ill patients and their families. The company operates within the healthcare and social assistance sectors, focusing on enhancing the quality of life for individuals nearing the end of life through a range of tailored services, including palliative care, counseling, and support programs.

How the Company Makes Money

Terminalcare Support Institute, Inc. generates revenue through a variety of channels, primarily through direct billing for its services to patients and their families. The company may also receive funding from insurance reimbursements, partnerships with healthcare providers, and government healthcare programs. In addition, it might engage in collaborations with hospitals and hospices to extend its reach and service offerings, ensuring a steady flow of referrals and engagements. These collaborations can also lead to grant opportunities or subsidies aimed at improving palliative care standards, further contributing to the company's income.

Terminalcare Support Institute, Inc. Financial Statement Overview

Summary

The company exhibits solid revenue growth and stable profitability with a 10.66% increase in revenue and a net profit margin of 2.40%. However, the increasing leverage with a Debt-to-Equity ratio of 2.14 and negative free cash flow indicate financial risks and potential cash flow management challenges.

Income Statement

The company has demonstrated consistent revenue growth, with a 10.66% increase from 2023 to 2024. Gross Profit Margin for 2024 was 14.08%, and Net Profit Margin was 2.40% indicating stable profitability levels. However, the EBIT and EBITDA margins show some variability, with EBIT Margin at 2.80% and EBITDA Margin at 5.29%, reflecting potential operating cost pressures.

Balance Sheet

The Debt-to-Equity Ratio has increased to 2.14, which suggests rising leverage levels. However, the Return on Equity (ROE) stands at 8.63%, showing effective utilization of equity for generating profits. The Equity Ratio is 27.29%, indicating a moderate equity base relative to total assets.

Cash Flow

The Free Cash Flow has been negative, reflecting a challenging situation in managing capital expenditures with operational cash flows. The Operating Cash Flow to Net Income Ratio is 2.69, indicating strong cash generation relative to net income. However, the Free Cash Flow to Net Income Ratio is negative, pointing to cash flow management issues.

Breakdown
Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
4.71B	4.25B	4.10B	3.40B	2.93B
	Gross Profit
664.67M	646.76M	685.84M	599.50M	464.84M
	EBIT
132.86M	110.54M	193.50M	172.26M	89.02M
	EBITDA
321.42M	300.83M	334.75M	284.93M	237.34M
	Net Income Common Stockholders
113.77M	126.67M	157.54M	138.03M	102.29M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
1.13B	1.38B	1.09B	874.72M	411.85M
	Total Assets
4.80B	4.09B	3.03B	2.88B	2.06B
	Total Debt
2.81B	2.26B	1.34B	1.43B	1.44B
	Net Debt
1.68B	878.35M	253.41M	556.53M	1.03B
	Total Liabilities
3.49B	2.90B	1.95B	1.95B	1.82B
	Stockholders Equity
1.31B	1.19B	1.08B	927.37M	237.34M
Cash Flow		Free Cash Flow
-797.40M	-597.43M	303.05M	-57.27M	51.51M
	Operating Cash Flow
304.51M	238.18M	812.73M	462.19M	124.89M
	Investing Cash Flow
-1.10B	-836.33M	-510.68M	-523.54M	-74.58M
	Financing Cash Flow
545.64M	892.46M	-90.11M	523.02M	-56.64M

Terminalcare Support Institute, Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 781.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7362, the sentiment is Negative. The current price of 781 is above the 20-day moving average (MA) of 780.55, below the 50-day MA of 786.40, and below the 200-day MA of 914.80, indicating a bearish trend. The MACD of -5.09 indicates Negative momentum. The RSI at 45.82 is Neutral, neither overbought nor oversold. The STOCH value of 42.53 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7362.

Terminalcare Support Institute, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7133	78 Outperform	¥10.55B	14.34		1.38%	20.50%	62.52%
9220	76 Outperform	¥2.52B	6.58		4.00%	5.85%	-22.29%
7129	75 Outperform	¥3.05B	9.58		3.11%	4.85%	4759.88%
2425	72 Outperform	¥3.02B	8.08		2.51%	2.33%	-0.96%
7061	69 Neutral	¥10.60B	19.16		1.19%	21.97%	-20.94%
7362	66 Neutral	¥1.20B	13.13		―	7.06%	-27.80%
Sector *	54 Neutral	$5.38B	3.40	-45.06%	3.28%	16.75%	-0.02%